secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2022-04-13T23:59:59+00:00
Accession:  0001104659-22-045308
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Michael Severino to step down as AbbVie Vice Chairman and President, effective May 31, 2022
--------------------------------------------------------------------------------

- Michael E. Severino will depart as Vice Chairman and President of AbbVie, effective May 31, 2022.
- Severino is leaving to become CEO-Partner at a bioplatform innovation company and CEO of one of its portfolio companies.
- No replacement has been announced for Severino's roles at AbbVie.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922045308/0001104659-22-045308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465922045308/tm2212581d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-045308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer